With the end of pandemic control measures severely reducing the demand for medical testing services, China’s laboratories are facing massive declines in revenue and laying off large portions of their staff.
StockNews.com upgraded shares of Chemed (NYSE:CHE – Free Report) from a hold rating to a buy rating in a report published on Saturday. Several other brokerages have also recently issued reports on CHE. Royal Bank of Canada boosted their price target on shares of Chemed from $604.00 to $712.00 and gave the company an outperform […]
Cervical cancer is preventable, yet a recent survey in Asia Pacific found that women are deprioritising screenings. Here's what you need to know about HPV, cervical cancer and why now is the time to #MakeTheMostImportantDate and get screened
Chemed (NYSE:CHE – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Saturday. Other equities research analysts have also issued research reports about the company. Oppenheimer lifted their price objective on Chemed from $625.00 to $650.00 and gave the […]
Penobscot Investment Management Company Inc. lessened its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 40.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,210 shares of the company’s stock after selling 820 shares during the quarter. Penobscot Investment […]